Skip to Main Content
OUTSOURCE EVERYTHING BUT THE GENIUS™

Welcome, Guest.

Go to Main Navigation

All About the “Value, Access and Evidence” Category

We are excited to introduce our newly expanded category Value, Evidence and Access and the accompanying rebranded Value, Evidence and Access Marketplace. The category will cover all the same areas as the previous “RWE & HEOR” category, as well as even more services to fully support the industry, including epidemiology and economic modeling, value evidence communications, reimbursement and market access, big data realization and more. The Marketplace includes even more signed suppliers, some offering discounts on services as part of our VIP program.

The Value, Evidence and Access Marketplace is an online solution that accelerates the sourcing and procurement process for researchers and suppliers of HEOR, RWE and Market Access services. By streamlining the process for buyers and sellers, the Marketplace will deliver reduced time to contract, quicker time to insight and faster market access. Here is what users can expect to find on the Marketplace:

  • Value: Value demonstration includes solutions that demonstrate product value, using robust evidence and compelling communications to inform healthcare decision-making.
  • Evidence: Evidence refers to all services and activities related to evidence development and synthesis, including real world evidence and real world data as well as modeling and clinical trials.
  • Access: Includes solutions to enable patient access to therapies through services that drive optimized market access using evidence-based value demonstration.

With the recent acquisition of HealthEconomics.Com, the world’s leading connected community for HEOR, RWE and Market Access professionals, buyers and suppliers now have access to relevant content, industry insights and business development solutions from our channel partner, HealthEconomics.Com, who has an audience of 30,000 stakeholders.

“The healthcare and pharmaceutical industries are increasingly using value-based approaches to evaluate new and existing therapies; Patti and her team at HealthEconomics.Com are the pioneers of this fast-growing area,” stated Kevin Lustig, PhD, CEO and founder of Scientist.com. “Combining our two platforms helps researchers evaluate and purchase critical Value, Access and Evidence solutions needed to improve patient access to high quality, cost-effective medicines.”

Please find more information on business development solutions for HealthEconomics.Com or get in contact with our team here (https://www.scientist.com/value-evidence-and-access/).

To register as a buyer or seller on the Value, Evidence and Access Marketplace, visit https://www.scientist.com/partners-healtheconomics/.